{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T21:49:48Z","timestamp":1794692988430,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471043"],"award-info":[{"award-number":["81471043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Bureau of Sichuan Province","award":["2015SZ0228-4"],"award-info":[{"award-number":["2015SZ0228-4"]}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2018SZ0239"],"award-info":[{"award-number":["2018SZ0239"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2019YFS0306"],"award-info":[{"award-number":["2019YFS0306"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Bureau of Chengdu citytion Commission","award":["2017-CY02-00028-GX"],"award-info":[{"award-number":["2017-CY02-00028-GX"]}]},{"name":"National Science and Technology Major Projec","award":["2017 ZX09304023"],"award-info":[{"award-number":["2017 ZX09304023"]}]},{"name":"Key Technologies Research and Development Program (CN)National Key R&D Program of China","award":["2017YFC1309605"],"award-info":[{"award-number":["2017YFC1309605"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13287-019-1254-5","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T05:56:25Z","timestamp":1558504585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Autologous stem cell therapy for peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"10","author":[{"given":"Wei","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwu","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"issue":"6","key":"1254_CR1","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","volume":"110","author":"E Selvin","year":"2004","unstructured":"Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110(6):738\u201343.","journal-title":"Circulation."},{"issue":"2","key":"1254_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jdiacomp.2017.10.003","volume":"32","author":"X Zhang","year":"2018","unstructured":"Zhang X, Ran X, Xu Z, Cheng Z, Shen F, Yu Y, et al. Epidemiological characteristics of lower extremity arterial disease in Chinese diabetes patients at high risk: a prospective, multicenter, cross-sectional study. J Diabetes Complicat. 2018;32(2):150\u20136.","journal-title":"J Diabetes Complicat"},{"issue":"6","key":"1254_CR3","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/ije\/25.6.1172","volume":"25","author":"GC Leng","year":"1996","unstructured":"Leng GC, Lee AJ, Fowkes FG, Whiteman M, Dunbar J, Housley E, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25(6):1172\u201381.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"1254_CR4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","volume":"297","author":"PG Steg","year":"2007","unstructured":"Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, R\u00f6ther J, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297(11):1197\u2013206.","journal-title":"JAMA."},{"issue":"1","key":"1254_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2006.03.011","volume":"189","author":"CL Heald","year":"2006","unstructured":"Heald CL, Fowkes FG, Murray GD, Price JF. Ankle Brachial Index CollaborationRisk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006;189(1):61\u20139.","journal-title":"Atherosclerosis."},{"issue":"3","key":"1254_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2337\/diaspect.21.3.171","volume":"21","author":"LM Steffen","year":"2008","unstructured":"Steffen LM, Duprez DA, Boucher JL, Ershow AG, Hirsch AT. Management of peripheral arterial disease. Diabetes Spectr. 2008;21(3):171\u20137.","journal-title":"Diabetes Spectr"},{"issue":"6","key":"1254_CR7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.jacc.2005.09.074","volume":"47","author":"HH Feringa","year":"2006","unstructured":"Feringa HH, van Waning VH, Bax JJ, Elhendy A, Boersma E, Schouten O, et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol. 2006;47(6):1182\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1254_CR8","doi-asserted-by":"publisher","first-page":"815S","DOI":"10.1378\/chest.08-0686","volume":"133","author":"M Sobel","year":"2008","unstructured":"Sobel M, Verhaeghe R. Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133(6 Suppl):815S\u201343S.","journal-title":"Chest."},{"issue":"8","key":"1254_CR9","first-page":"CD005263","volume":"23","author":"HJ Fokkenrood","year":"2013","unstructured":"Fokkenrood HJ, Bendermacher BL, Lauret GJ, Willigendael EM, Prins MH, Teijink JA. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2013;23(8):CD005263.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1254_CR10","first-page":"CD000986","volume":"30","author":"L Robertson","year":"2013","unstructured":"Robertson L, Andras A. Prostanoids for intermittent claudication. Cochrane Database Syst Rev. 2013;30(4):CD000986.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1254_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/01.CIR.102.4.426","volume":"102","author":"M Li\u00e8vre","year":"2000","unstructured":"Li\u00e8vre M, Morand S, Besse B, Fiessinger JN, Boissel JP. Oral Beraprost sodium, a prostaglandin I (2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Circulation. 2000;102(4):426\u201331.","journal-title":"Circulation."},{"issue":"12","key":"1254_CR12","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/S0002-9149(02)02869-2","volume":"90","author":"PD Thompson","year":"2002","unstructured":"Thompson PD, Zimet R, Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol. 2002;90(12):1314\u20139.","journal-title":"Am J Cardiol"},{"issue":"14","key":"1254_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14140","volume":"14","author":"AW Bradbury","year":"2010","unstructured":"Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Health Technol Assess. 2010;14(14):1\u2013210 iii-iv.","journal-title":"Health Technol Assess"},{"key":"1254_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coph.2018.01.005","volume":"39","author":"NG Frangogiannis","year":"2018","unstructured":"Frangogiannis NG. Cell therapy for peripheral artery disease. Curr Opin Pharmacol. 2018;39:27\u201334.","journal-title":"Curr Opin Pharmacol"},{"issue":"Suppl 1","key":"1254_CR15","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.ejvs.2009.12.001","volume":"39","author":"RW Sprengers","year":"2010","unstructured":"Sprengers RW, Moll FL, Verhaar MC. Stem cell therapy in PAD. Eur J Vasc Endovasc Surg. 2010;39(Suppl 1):S38\u201343.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"1254_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12262-009-0059-7","volume":"71","author":"AK Das","year":"2009","unstructured":"Das AK. Stem cell therapy for critical limb ischaemia - a review. Indian J Surg. 2009;71(4):177\u201381.","journal-title":"Indian J Surg"},{"issue":"5302","key":"1254_CR17","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.275.5302.964","volume":"275","author":"T Asahara","year":"1997","unstructured":"Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275(5302):964\u20137.","journal-title":"Science."},{"issue":"4","key":"1254_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/7434","volume":"5","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5(4):434\u20138.","journal-title":"Nat Med"},{"issue":"9","key":"1254_CR19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/hc3501.093817","volume":"104","author":"H Kamihata","year":"2001","unstructured":"Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001;104(9):1046\u201352.","journal-title":"Circulation."},{"issue":"7","key":"1254_CR20","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1073\/pnas.97.7.3422","volume":"97","author":"C Kalka","year":"2000","unstructured":"Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97(7):3422\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1254_CR21","doi-asserted-by":"publisher","first-page":"E174","DOI":"10.25011\/cim.v33i3.13723","volume":"33","author":"J Meng","year":"2010","unstructured":"Meng J, Yao X, Kang S, Kang S, Yang Y, Zhou C. Treatment of ischemic limbs by transplantation of G-CSF stimulated bone marrow cells in diabetic rabbits. Clin Invest Med. 2010;33(3):E174\u201380.","journal-title":"Clin Invest Med"},{"issue":"9331","key":"1254_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","volume":"360","author":"E Tateishi-Yuyama","year":"2002","unstructured":"Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360(9331):427\u201335.","journal-title":"Lancet."},{"issue":"8","key":"1254_CR23","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.116.309045","volume":"120","author":"M Rigato","year":"2017","unstructured":"Rigato M, Monami M, Fadini GP. Autologous cell therapy for peripheral arterial disease: systematic review and meta-analysis of randomized, nonrandomized, and noncontrolled studies. Circ Res. 2017;120(8):1326\u201340.","journal-title":"Circ Res"},{"key":"1254_CR24","unstructured":"ClinicalTrials.gov. Why should I register and submit results? \n                    http:\/\/www.clinicaltrials.gov\/ct2\/manage-recs\/background\n                    \n                  . Accessed 10 Aug 2018."},{"key":"1254_CR25","unstructured":"Online The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions [EB\/OL]. [2009-09-01]. \n                    http:\/\/www.cochrane.org\/.htm\n                    \n                  . Accessed 6 Oct 2018."},{"issue":"7650","key":"1254_CR26","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ."},{"issue":"9","key":"1254_CR27","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.2337\/diacare.28.9.2155","volume":"28","author":"P Huang","year":"2005","unstructured":"Huang P, Li S, Han M, Xiao Z, Yang R, Han ZC. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care. 2005;28(9):2155\u201360.","journal-title":"Diabetes Care"},{"issue":"4","key":"1254_CR28","first-page":"155","volume":"12","author":"P Bar\u0107","year":"2006","unstructured":"Bar\u0107 P, Sk\u00f3ra J, Pupka A, Turkiewicz D, Dorobisz AT, Garcarek J, et al. Bone-marrow cells in therapy of critical limb ischaemia of lower extremities-own experience. Acta Angiol. 2006;12(4):155\u201366.","journal-title":"Acta Angiol"},{"issue":"9","key":"1254_CR29","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1253\/circj.70.1093","volume":"70","author":"M Arai","year":"2006","unstructured":"Arai M, Misao Y, Nagai H, Kawasaki M, Nagashima K, Suzuki K, et al. Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease. Circ J. 2006;70(9):1093\u20138.","journal-title":"Circ J"},{"issue":"8","key":"1254_CR30","first-page":"58","volume":"8","author":"Z Zhang","year":"2007","unstructured":"Zhang Z, Liu W, Zhao X. Transplantation of autologous bone marrow stem cell for diabetic foot ulcer. Pract Clin Med. 2007;8(8):58\u201360.","journal-title":"Pract Clin Med"},{"issue":"2","key":"1254_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1000-1948(08)60031-3","volume":"23","author":"D Lu","year":"2008","unstructured":"Lu D, Jiang Y, Liang Z, Li X, Zhang Z, Chen B. Autologous transplantation of bone marrow mesenchymal stem cells on diabetic patients with lower limb ischemia. J Med Coll PLA. 2008;23(2):106\u201315.","journal-title":"J Med Coll PLA"},{"issue":"5","key":"1254_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/rej.2009.0872","volume":"12","author":"NR Dash","year":"2009","unstructured":"Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res. 2009;12(5):359\u201366.","journal-title":"Rejuvenation Res"},{"issue":"32","key":"1254_CR33","first-page":"6227","volume":"13","author":"B Chen","year":"2009","unstructured":"Chen B, Lu D, Liang Z, Jiang Y, Wang F, Wu Q, et al. Autologous bone marrow mesenchymal stem cell transplantation for treatment of diabetic foot following amplification in vitro. Chin J Tissue Eng Res. 2009;13(32):6227\u201330.","journal-title":"Chin J Tissue Eng Res"},{"issue":"1","key":"1254_CR34","first-page":"5","volume":"8","author":"Y Gan","year":"2009","unstructured":"Gan Y, Li T, Yu L, Zheng C, Dong L, Jin R, et al. Curative effect of the combination of autologous bone marrow stem cell transplantation and Tongmai Huayu soup on diabetic foot. Chin J Dermatovenereol Integrated Tradit Western Med. 2009;8(1):5\u20137.","journal-title":"Chin J Dermatovenereol Integrated Tradit Western Med"},{"issue":"34","key":"1254_CR35","first-page":"50","volume":"32","author":"J Shi","year":"2009","unstructured":"Shi J, Yan Z, Hu X, Cao L, Zhang X, Ma X. Clinical study of autologous bone marrow hematopoietic stem cell transplantation for treatment of diabetic lower limb vascular lesions. Chin J Postgraduates Med. 2009;32(34):50\u20132.","journal-title":"Chin J Postgraduates Med"},{"issue":"11","key":"1254_CR36","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3727\/096368910X514170","volume":"19","author":"V Proch\u00e1zka","year":"2010","unstructured":"Proch\u00e1zka V, Gumulec J, Jal\u016fvka F, Salounov\u00e1 D, Jonszta T, Czern\u00fd D, et al. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant. 2010;19(11):1413\u201324.","journal-title":"Cell Transplant"},{"issue":"45","key":"1254_CR37","first-page":"8526","volume":"14","author":"J Wen","year":"2010","unstructured":"Wen J, Huang P. Autologous peripheral blood mononuclear cells transplantation in treatment of 30 cases of critical limb ischemia: 3-year safety follow-up. J Clin Rehabil Tissue Eng Res. 2010;14(45):8526\u201330.","journal-title":"J Clin Rehabil Tissue Eng Res"},{"issue":"1","key":"1254_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1161\/CIRCINTERVENTIONS.110.958348","volume":"4","author":"DH Walter","year":"2011","unstructured":"Walter DH, Krankenberg H, Balzer JO, Kalka C, Baumgartner I, Schl\u00fcter M, et al. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv. 2011;4(1):26\u201337.","journal-title":"Circ Cardiovasc Interv."},{"issue":"6","key":"1254_CR39","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.jvs.2011.06.118","volume":"54","author":"MD Iafrati","year":"2011","unstructured":"Iafrati MD, Hallett JW, Geils G, Pearl G, Lumsden A, Peden E, et al. Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia. J Vasc Surg. 2011;54(6):1650\u20138.","journal-title":"J Vasc Surg"},{"key":"1254_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1479-5876-9-165","volume":"9","author":"E Benoit","year":"2011","unstructured":"Benoit E, O'Donnell TF Jr, Iafrati MD, Asher E, Bandyk DF, Hallett JW, et al. The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design. J Transl Med. 2011;9:165.","journal-title":"J Transl Med"},{"issue":"4","key":"1254_CR41","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jvs.2011.04.006","volume":"52","author":"RJ Powell","year":"2011","unstructured":"Powell RJ, Comerota AJ, Berceli SA, Guzman R, Henry TD, Tzeng E, et al. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia. J Vasc Surg. 2011;52(4):1032\u201341.","journal-title":"J Vasc Surg"},{"issue":"6","key":"1254_CR42","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/mt.2012.52","volume":"20","author":"RJ Powell","year":"2012","unstructured":"Powell RJ, Marston WA, Berceli SA, Guzman R, Henry TD, Longcore AT, et al. Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the 25 randomized, double-blind, placebo-controlled RESTORE-CLI trial. Mol Ther. 2012;20(6):1280\u20136.","journal-title":"Mol Ther"},{"issue":"1","key":"1254_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","volume":"92","author":"D Lu","year":"2011","unstructured":"Lu D, Chen B, Liang Z, Deng W, Jiang Y, Li S, et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract. 2011;92(1):26\u201336.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1254_CR44","first-page":"90","volume":"10","author":"W Guan","year":"2011","unstructured":"Guan W, Gan Y, Li T, Yu L, Zheng C, Jia P, et al. Curative effect of autologous bone marrow stem cell transplantation on diabetic foot and its relation with serum level of basic fibroblast growth factor. Chin J Dermatovenereol Integrated Tradit Western Med. 2011;10(2):90\u20132.","journal-title":"Chin J Dermatovenereol Integrated Tradit Western Med"},{"issue":"7","key":"1254_CR45","first-page":"38","volume":"57","author":"P Jain","year":"2011","unstructured":"Jain P, Perakath B, Jesudason MR, Nayak S. The effect of autologous bone marrow-derived cells on healing chronic lower extremity wounds: results of a randomized controlled study. Ostomy Wound Management. 2011;57(7):38\u201344.","journal-title":"Ostomy Wound Management"},{"issue":"1","key":"1254_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jdiacomp.2011.11.007","volume":"26","author":"A Ozturk","year":"2012","unstructured":"Ozturk A, Kucukardali Y, Tangi F, Erikci A, Uzun G, Bashekim C, et al. Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia. J Diabetes Complicat. 2012;26(1):29\u201333.","journal-title":"J Diabetes Complicat"},{"issue":"6","key":"1254_CR47","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1161\/CIRCINTERVENTIONS.112.968321","volume":"5","author":"DW Losordo","year":"2012","unstructured":"Losordo DW, Kibbe MR, Mendelsohn F, Marston W, Driver VR, Sharafuddin M, et al. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia. Circ Cardiovasc Interv. 2012;5(6):821\u201330.","journal-title":"Circ Cardiovasc Interv"},{"issue":"5","key":"1254_CR48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.6002\/ect.2012.0129","volume":"11","author":"M Li","year":"2013","unstructured":"Li M, Zhou H, Jin X, Wang M, Zhang S, Xu L. Autologous bone marrow mononuclear cells transplant in patients with critical leg ischemia: preliminary clinical results. Exp Clin Transplant. 2013;11(5):435\u20139.","journal-title":"Exp Clin Transplant"},{"issue":"10","key":"1254_CR49","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jcyt.2013.05.017","volume":"15","author":"GV Szabo","year":"2013","unstructured":"Szabo GV, Kovesd Z, Cserepes J, Daroczy J, Belkin M, Acsady G. Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short- and long-term follow-up. Cytotherapy. 2013;15(10):1245\u201352.","journal-title":"Cytotherapy."},{"issue":"1","key":"1254_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-0032-1311646","volume":"121","author":"L Mohammadzadeh","year":"2013","unstructured":"Mohammadzadeh L, Samedanifard SH, Keshavarzi A, Alimoghaddam K, Larijani B, Ghavamzadeh A, et al. Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia. Exp Clin Endocrinol Diabetes. 2013;121(1):48\u201353.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"12","key":"1254_CR51","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.jcyt.2014.07.011","volume":"16","author":"AN Raval","year":"2014","unstructured":"Raval AN, Schmuck EG, Tefera G, Leitzke C, Ark CV, Hei D, et al. Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial. Cytotherapy. 2014;16(12):1720\u201332.","journal-title":"Cytotherapy."},{"issue":"10","key":"1254_CR52","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","volume":"131","author":"M Teraa","year":"2015","unstructured":"Teraa M, Sprengers RW, Schutgens RE, Slaper-Cortenbach IC, van der Graaf Y, Algra A, et al. Effect of repetitive intraarterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) trial. Circulation. 2015;131(10):851\u201360.","journal-title":"Circulation."},{"issue":"2","key":"1254_CR53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5114\/aoms.2013.39935","volume":"11","author":"J Sk\u00f3ra","year":"2015","unstructured":"Sk\u00f3ra J, Pupka A, Janczak D, Bar\u0107 P, Dawiskiba T, Korta K, et al. Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia. Arch Med Sci. 2015;11(2):325\u201331.","journal-title":"Arch Med Sci"},{"issue":"4","key":"1254_CR54","first-page":"402","volume":"48","author":"A Lu","year":"2016","unstructured":"Lu A, Zhao J, Zhang S, Li D, Zhang L, Nan J. The clinical observation of 20 cases of diabetic vascular lesion of lower limbs treated with autologous peripheral blood stem cell transplant after bone marrow mobilization. Inner Mongolia Med J. 2016;48(4):402\u20134.","journal-title":"Inner Mongolia Med J"},{"key":"1254_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1479-5876-11-143","volume":"10","author":"PK Gupta","year":"2013","unstructured":"Gupta PK, Chullikana A, Parakh R, Desai S, Das A, Gottipamula S, et al. A double blind randomized placebo controlled phase I\/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia. J Transl Med. 2013;10:143.","journal-title":"J Transl Med"},{"issue":"2","key":"1254_CR56","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2009.07.050","volume":"208","author":"T Horie","year":"2010","unstructured":"Horie T, Onodera R, Akamastu M, Ichikawa Y, Hoshino J, Kaneko E, et al. Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells. Atherosclerosis. 2010;208(2):461\u20136.","journal-title":"Atherosclerosis."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1254-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-019-1254-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1254-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T19:22:25Z","timestamp":1589916145000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-019-1254-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1254"],"URL":"https:\/\/doi.org\/10.1186\/s13287-019-1254-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"assertion":[{"value":"30 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"140"}}